Interesting timeline when you consider that according to the Nov...

Interesting timeline when you consider that according to the Nov 2021 letter to shareholders page 3, FDA pre-submission meeting was scheduled in for December 2021. Did this still go ahead? If so, it seems pretty coincidental that a confidentially agreement was signed with Pfizer on or immediately after.

Anyone able to shed further light on what this all means.
For me this has got current shareholders getting reemed written all over it unfortunately...

Happy to stand corrected in any of my posts.

Nov 2021 - Page 3
"The US is the world’s largest healthcare market and we continue to make progress towards US FDA approval for our cough-based algorithms. Earlier this year we requested a Pre-Submission meeting with the FDA and, after a COVID-19-related delay, I’m pleased to confirm that we now have a meeting scheduled for December."